drugset / Trial / NCT00140569

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

NCT00140569

Phase 3 Completed 400 enrolled Lymphoma Study Association
RandomizedParallel-groupOpen-labelTreatment

Summary

2 parallel studies. * For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI * For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months

Timeline

Start
1994-01
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fludarabine Small molecule 20 mg/m2

Indications